ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tyers, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tyers, G. F.

The Annals of Thoracic Surgery, Vol 48, 390-396, Copyright © 1989 by The Society of Thoracic Surgeons


ARTICLES

FDA recalls: how do pacemaker manufacturers compare?

GF Tyers
Division of Cardiovascular and Thoracic Surgery, University of British Columbia, Vancouver, Canada.

To evaluate an apparent perception that there is no difference in reliability among the products of the major cardiac pacing system manufacturers, an extensive review of US Food and Drug Administration regulatory actions was performed. The study period was July 1974 through June 1987. The total number of affected devices was collected for each manufacturer. Available sales data were used to calculate their percentage of recalled products during two time periods. The percentage of potentially high-risk devices (Food and Drug Administration class I and II recalls) was high for one company, moderate for one, and relatively low for the rest. Potential biases in some other sources of reliability information, as well as implications for regulatory policies, are discussed. The data reported establish that there have been past deficiencies in recall management. Although further pacing device recalls are probable, appropriate early regulatory and manufacturer action should help to assure that both the immense cost and patient distress caused by pacer and related product problems in the past can be minimized in the future.


This article has been cited by other articles:


Home page
EuropaceHome page
A. Auricchio, M. Gropp, S. Ludgate, P. Vardas, J. Brugada, S. G. Priori, and Writing Committee for the European Heart Rhythm As
European Heart Rhythm Association Guidance Document on cardiac rhythm management product performance.
Europace, January 1, 2006; 8(5): 313 - 322.
[Full Text] [PDF]


Home page
JAMAHome page
W. H. Maisel, M. O. Sweeney, W. G. Stevenson, K. E. Ellison, and L. M. Epstein
Recalls and Safety Alerts Involving Pacemakers and Implantable Cardioverter-Defibrillator Generators
JAMA, August 15, 2001; 286(7): 793 - 799.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 by The Society of Thoracic Surgeons.